LYEL logo
LYEL

Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc. (LYEL) Earnings

Last reported
March 31, 2026
EPS Beat · +54.4%
EPS estimate
-$2.41
EPS actual
-$1.10
Revenue est.
Revenue actual